bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – Should You Buy?

bioMerieux (OTCMKTS:BMXMF)’s share price gapped up before the market opened on Friday . The stock had previously closed at $109.61, but opened at $115.00. bioMerieux shares last traded at $115.00, with a volume of 1,012 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, BNP Paribas Exane downgraded bioMerieux to a “neutral” rating in a report on Wednesday, January 28th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, bioMerieux has an average rating of “Hold”.

bioMerieux Trading Up 4.9%

The stock’s 50-day moving average price is $120.59 and its 200-day moving average price is $128.15. The company has a current ratio of 2.27, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08.

About bioMerieux

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.